 Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss

Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss buy - large image1

Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss buy - image1

Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss buy - image2

Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss buy - image3

Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss buy - image4

Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss

Name: Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss
Brand: No Brand
SKU: pr2609111014
Price: 8 USD
Availability: InStock

TDS 7484 Inquiries

Unit Price: Get Latest Price 

CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ShenZhen

Brand:

No Brand

Packaging:

5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g

Sample Available:

Yes

Price valid (until):

2026-10-16

Contact Supplier

 Chat Now

PLANOVO BIOTECH CO., LTD

Company Type:

Trader

Location:

China

Payment Terms:

TT against copy of documents,100% TT in advance

Qualification:

Main Products:

Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

 Visit Store

Product Details
Seller Information
History Price
Inquiry History

Description

FAQ

Q1: Can I place a trial order for one vial?
A: Yes, trial orders are acceptable.

Q2: What payment terms do you support?
A: We accept T/T, PayPal, bank transfer and other payment methods. Please pick the one most convenient for you.

Q3: What is the lead time and shipping option?
A: We ship by international couriers (DHL, UPS, FedEx) or air freight. Delivery time to your address is approximately 8‑10 business days.

whatsapp:+86 13248433458

Shop Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss-Detailed Image 4

Shop Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss-Detailed Image 5

Ordering Information

Standard specifications listed in the catalog are available in stock. For special specifications and batch requirements, please contact our sales team to confirm lead time.
Batch traceability: Each batch is assigned a unique batch number. Full COA is available, including purity, molecular weight and sequence verification results.
Custom synthesis: We support sequence modifications (acetylation, amidation, fatty acid modification, etc.), fluorescent / biotin labeling, stable isotope labeling and impurity profile control. • Technical support: Technical consultation and literature support are provided, covering reconstitution, storage and experimental protocol design.
Packaging & Shipping: Standard cold‑chain shipping is offered. Aliquot service is available upon lab request to avoid repeated freeze‑thaw cycles.
Customer scope: Products are only supplied to universities, research institutes, hospital laboratories and biomedical enterprises with R&D qualifications.
Quality assurance: All products undergo strict quality testing before delivery. Any quality complaints supported by valid test data will be handled promptly. Order adjustment: Notify our sales team at least 3 working days in advance if you need to modify or cancel confirmed orders. Changes after shipment cannot be accepted.
Payment terms: Multiple payment options are available for qualified customers. Extended credit terms can be discussed based on long-term cooperation.
Confidentiality: Custom synthesis projects and your research information will be kept strictly confidential and will not be disclosed to any third parties.
After-sales service: Our technical team remains accessible after delivery to solve problems encountered during sample preparation and experiments.

Product Name	Retatrutide Powder
Name	Retatrutide
Type	Lyophilized Powder
storage	Store in a cool and dark place
CAS No	2381089-83-2
Purity	≥99%
Specific	5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g
Package	10 vials/box

Product Features

High Purity: Manufactured by solid-phase peptide synthesis. HPLC purity ≥99%. Each batch is fully tested and verified.
Complete Batch Traceability: Every lot is assigned a unique batch number. Full COA documents are provided, including HPLC purity report, mass spectrometry molecular weight identification and sequence verification data.
Reliable Peptide Modification: Optimized fatty acid side-chain modification extends the half-life, supporting research on long-acting metabolic regulation.
Research Use Only: This product is strictly for laboratory research purposes, not for human or animal clinical treatment.
Mechanism of Action

Retatrutide activates three key metabolic receptors simultaneously. It suppresses appetite and reduces food intake via GLP‑1 and GIP pathways, while GCGR activation elevates energy consumption. The combined triple-pathway effect delivers superior weight-lowering and glucose-controlling effects compared with dual receptor agonists. Its regulatory mode mimics the body’s natural metabolic hormone balance. In clinical research, gastrointestinal reactions are common adverse responses. The safety profile needs to be evaluated according to research data.

Research Application

Suitable for in vitro cell assays, in vivo animal model studies, mechanism exploration of obesity, type 2 diabetes, lipid disorders and related metabolic disorders. Widely used in university labs, research institutes, hospital research centers and biomedical R&D enterprises.

Specifications & Packaging
- Item: Retatrutide
- Available strength: 10mg/vial (custom concentrations and packaging available)
- Form: Lyophilized powder
- Storage: Long-term storage at -20℃, avoid repeated freeze-thaw.
- Shipping: Cold chain transportation. Aliquot service is available upon request to prevent sample degradation caused by multiple freeze-thaw cycles.

ECHEMI Editorial Reference

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

Certificates

Basic Info

Product Name:

Retatrutide

Other Name:

Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

CAS No.:

2381089-83-2

InChIKeys:

MLOLQJNKXBNWFW-SAGGEDDASA-N

Molecular Weight:

EC Number:

200-001-8

Color/Form:

White lyophilized

Categories:

Polypeptide

Characteristics

Water Solubility:

Soluble in water (5mg/ml).

Storage Conditions:

-20°C

Critical Temperature & Pressure:

-20°C

Research

Class:

Triple agonist — GCGR, GIPR, GLP-1R

Status:

Investigational (Phase 3)

Mechanism:

Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

EC50 (Human GCGR):

5.79 nM

EC50 (Mouse GIPR):

0.191 nM

EC50 (Mouse GLP1R):

0.794 nM

EC50 (Mouse GCGR):

2.32 nM

EC50 (Human GLP1R):

0.775 nM

EC50 (Human GIPR):

0.0643 nM

Source:

Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

Clinical Development:

NCT04881760; NCT05882045; NCT06354660

References

ChEMBL:

DrugBank:

KEGG DRUG:

PubChem:

Literature:

NEJM: Jastreboff et al. (2023) — Phase 2 Trial; FDA Drugs@FDA

Disclaimer:

Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

See More Retatrutide Properties 

Seller Information

Business Type:
Trader

Main Products:
Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

Location:
18 Linchang, Wujin district, Changzhou, China

Payment Terms:
TT against copy of documents,100% TT in advance

Total Annual Revenue:
$5 million-$10 million

Total Employees:
51-100

Year of Establishment:
2026
Company Profile

HANGZHOU PLANOVO BIOTECH CO LTD. was officially established on August 25, 2016, at Linchang Group, Mandun Village, Jiaze Town, Wujin District, Changzhou, Jiangsu Province, China. As an innovative enterprise dedicated to the biotechnology sector, the company has quickly made its mark in the industry through outstanding R&D capabilities, rigorous quality control, and a diversified business portfolio, guided by its corporate philosophy of "Quality First, Customer Supreme, Innovation-driven, Integrity in Service."

Business Scope

The company's business covers a wide range of areas:
- Biotechnology and Medical Device R&D Consulting: Focusing on frontier biotechnology research and driving the translation of scientific achievements into practical applications;
- Cosmetics Production and Sales: Offering high-quality cosmetic products built on a mature R&D and manufacturing system;
- Medical Device Manufacturing and Sales: Covering Class I, Class II, and Class III medical devices, strictly in accordance with the approved scope of relevant licenses.
R&D Strength

The company has an R&D team composed of senior researchers and professional technical talents who uphold the spirit of innovation and focus on R&D and consulting services in biotechnology and medical device technology. The team continuously explores cutting-edge technologies, dedicated to converting the latest scientific research results into practical applications and providing a steady stream of momentum for product innovation.

Main Product： Tirzepatide/Retatrutide/Semaglutide/CBL-514/Peptide/GLP-1/GHK-CU/NAD+
Weekly Price

 The chart shows the price trend of the product in the past 12 months.

Inquiry History

7484 Inquiries

Country	Product	Purchase Quantity	Date Posted
United States	Retatrutide	1 G	Oct 27, 2026
United Kingdom	Retatrutide	10 MG	Oct 27, 2026
Lithuania	Retatrutide	30 MG	Oct 27, 2026
United States	Retatrutide	10 MG	Oct 27, 2026
Greece	Retatrutide	30 MG	Oct 27, 2026
Germany	Retatrutide	20 MG	Oct 27, 2026
Canada	Retatrutide	30 MG	Oct 27, 2026
United States	retatrutide	40 MG	Oct 27, 2026
Spain	Retatrutide	30 MG	Oct 27, 2026
United Kingdom	Retatrutide	20 MG	Oct 27, 2026
United States	Retatrutide	40 MG	Oct 27, 2026
United States	Retatrutide	50 MG	Oct 27, 2026
United States	retatrutide	30 MG	Oct 27, 2026
United States	retatrutide	200 MG	Oct 27, 2026
Spain	retatrutide	200 MG	Oct 27, 2026
United States	Retatrutide	100 PCS	Oct 27, 2026
New Zealand	Retatrutide	20 PCS	Oct 27, 2026
Netherlands	Retatrutide	100 20' Fcl	Oct 27, 2026
United States	Retatrutide	300 MG	Oct 27, 2026
Canada	Retatrutide	1 G	Oct 26, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
99%+ high purity Retatrutide CAS 2381089-83-2 peptides Lyophilized Powder vilas for research Use	Pharmaceutical Grade/99	$1/UNIT FOB	Hangzhou Zhongma Trading Co., Ltd.	Inquiry
Retatrutide CAS 2381089-83-2 99% Hot Sale Pharmaceutical Best Service Pharmaceutical Producer RT20 RT50 RT60	Pharmaceutical Grade/99	$33/MT FOB	Yiwu Xichai Biotechnology Co., Ltd.	Inquiry
Retatrutida \| 99% de Pureza \| Direto do Fabricante \|Envio para Todo o Mundo \| Brinde Incluso 2381089-83-2	Pharmaceutical Grade/99	$33-36/UNIT FOB	Jielu Trading	Inquiry
Peptide Retatrutide CAS 2381089-83-2 Ly3437943 Weight Loss Retatrutide 5mg 10mg Vials 99% High Concentrate Quality	Pharmaceutical Grade/99	$2.3-2.5/UNIT EXW	Dongguan Chenguang Technology Co., Ltd.	Inquiry
Retatrutide Peptide 30mg GMP Direct Supply Quick Shipping	Pharmaceutical Grade/99	$165.3/UNIT FOB	QingDao NuoChenJian Technology Co.,LTD	Inquiry

Retatrutide Semaglutide 99.5% API raw material lyophilized peptidesWeight loss

Product Details

Seller Information

History Price

Inquiry History

Ordering Information

Mechanism of Action

Research Application

Specifications & Packaging

Company Profile

Business Scope

R&D Strength

More Choices Find All Products for Sale 

Related Searches

More from this Seller